+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Cimifugin

BP0356
37921-38-3
98%
Biopurify
Cimifugin evidently inhibits FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines. Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 ug/mL. Cimifugin is an organic heterotricyclic compound and an oxacycle.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0356-20mg 20mg
BP0356-100mg 100mg
BP0356-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

RELA MAPK1 TNF NOS2 MMP9 PTGS2 IL6 IL1B CXCL8 HMGB1 NFKBIA
RELA TNF NOS2 PTGS2 IL6 IL4 IL13 HMGB1 NFKBIA TSLP TJP1
RELA MAPK1 TNF PTGS2 IL6 IL4 IL13 TJP1
RELA TNF NOS2 PTGS2 IL6 IL1B CXCL8 HMGB1 NFKBIA TJP1

Product drug property prediction parameters

  • 89.1300

  • 1.0715

  • 1.0713

  • .3352

  • 1.1426

  • 6.4954

  • High

  • 72.9847

  • 3.5333

  • Yes

  • No

  • No

  • No

  • Yes

  • Yes

  • 0.9

  • Yes

  • No

  • Yes

  • Yes